[Controlled clinical study of the oral use of Ketoscilium in dyskinetic-spastic disorders of the digestive tract].
D001532:Atropa belladonna / Q000627:therapeutic use*; D005767:Gastrointestinal Diseases / Q000188:drug therapy*; D005769:Gastrointestinal Motility; D006801:Humans; D010276:Parasympatholytics / Q000627:therapeutic use*; D008517:Phytotherapy; D010946:Plants, Medicinal; D010947:Plants, Toxic; D011413:Propantheline / Q000627:therapeutic use; D000644:Quaternary Ammonium Compounds / Q000627:therapeutic use*; D014966:Xanthenes / Q000627:therapeutic use*
D010276:Parasympatholytics; D000644:Quaternary Ammonium Compounds; D014966:Xanthenes; D011413:Propantheline
Studio clinico controllato sull'impiego orale del Ketoscilium in forme discinetico-spastiche dell'apparato digerente.